EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
07/10/2025
Back to search
Official data from USPTO
REALWAVE NEUROPATHY TREATMENT CENTERS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
REALWAVE NEUROPATHY TREATMENT CENTERS
ST13
US500000097026802Class
44
Filing
97026802
Registration
6883553
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
17
Latest update
07/16/2025
Classification
Registered
Trademark type
Word
Nice classes
44
Filing date
09/14/2021
Registration date
10/25/2022
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/25/2022
Last transaction
07/16/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
05/04/2021
First use in commerce
05/04/2021
Drawing code
4
Owner type
16
Owner location
Billings, MT
Examiner
GULIANO, ROBERT
Law office
L50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Amylase Technologies LLC
Representatives
Aaron W. Nicholson CROWLEY FLECK PLLP
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Medical diagnosis and treatment of peripheral neuropathy; Medical diagnosis of peripheral neuropathy; Medical evaluation of peripheral neuropathy; Medical services, namely, evaluation and treatment of peripheral neuropathy; Medical testing for diagnostic or treatment purposes in the field of peripheral neuropathy; Medical treatment of peripheral neuropathy
Publications
History of USPTO decisions and trademark events.
17 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/10/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/10/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/10/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/25/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
10/25/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/09/2022
PUBO
PUBLISHED FOR OPPOSITION
08/09/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/20/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/05/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
06/21/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/21/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
06/21/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/21/2022
DOCK
ASSIGNED TO EXAMINER
06/16/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/20/2021
NWAP
NEW APPLICATION ENTERED
09/17/2021
Continuous trademark protection
Get notified about every new filing that threatens REALWAVE NEUROPATHY TREATMENT CENTERS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.